4.6 Article

Interplay between Mutations and Efflux in Drug Resistant Clinical Isolates of Mycobacterium tuberculosis

Related references

Note: Only part of the references are listed.
Review Infectious Diseases

Mycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectives

T. Schon et al.

CLINICAL MICROBIOLOGY AND INFECTION (2017)

Review Infectious Diseases

Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy

Caroline M. Pule et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)

Review Infectious Diseases

Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement

J. Dominguez et al.

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2016)

Article Microbiology

How to Measure Export via Bacterial Multidrug Resistance Efflux Pumps

Jessica M. A. Blair et al.

Article Critical Care Medicine

Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study

Louise J. Pankhurst et al.

LANCET RESPIRATORY MEDICINE (2016)

Article Pharmacology & Pharmacy

Lipid transport in Mycobacterium tuberculosis and its implications in virulence and drug development

Rebeca Bailo et al.

BIOCHEMICAL PHARMACOLOGY (2015)

Article Infectious Diseases

Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015

Y. Zhang et al.

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2015)

Article Biotechnology & Applied Microbiology

Study of efflux pump gene expression in rifampicin-monoresistant Mycobacterium tuberculosis clinical isolates

Guilian Li et al.

JOURNAL OF ANTIBIOTICS (2015)

Article Chemistry, Medicinal

Rational Design and Synthesis of Thioridazine Analogues as Enhancers of the Antituberculosis Therapy

Marco Pieroni et al.

JOURNAL OF MEDICINAL CHEMISTRY (2015)

Review Pharmacology & Pharmacy

Exploring the potential of adjunct therapy in tuberculosis

Geetha Vani Rayasaml et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2015)

Article Microbiology

Efflux Inhibition with Verapamil Potentiates Bedaquiline in Mycobacterium tuberculosis

Shashank Gupta et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)

Review Microbiology

Energy Metabolism and Drug Efflux in Mycobacterium tuberculosis

Philippa A. Black et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)

Article Microbiology

Reduced Emergence of Isoniazid Resistance with Concurrent Use of Thioridazine against Acute Murine Tuberculosis

Noton K. Dutta et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)

Article Multidisciplinary Sciences

Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline

Koen Andries et al.

PLOS ONE (2014)

Article Critical Care Medicine

Acceleration of Tuberculosis Treatment by Adjunctive Therapy with Verapamil as an Efflux Inhibitor

Shashank Gupta et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)

Article Microbiology

Role of the Mmr Efflux Pump in Drug Resistance in Mycobacterium tuberculosis

Liliana Rodrigues et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)

Article Microbiology

Functional and Genetic Characterization of the Tap Efflux Pump in Mycobacterium bovis BCG

Santiago Ramon-Garcia et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)

Review Infectious Diseases

Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs

Miguel Viveiros et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)

Article Critical Care Medicine

Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistant Mycobacterium tuberculosis through Efflux

Gail E. Louw et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Article Infectious Diseases

Role of P27-P55 operon from Mycobacterium tuberculosis in the resistance to toxic compounds

Maria V. Bianco et al.

BMC INFECTIOUS DISEASES (2011)

Article Biochemistry & Molecular Biology

Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism

Kristin N. Adams et al.

Review Infectious Diseases

The ins and outs of Mycobacterium tuberculosis drug susceptibility testing

E. C. Boettger

CLINICAL MICROBIOLOGY AND INFECTION (2011)

Review Chemistry, Medicinal

Recent progress in biological activities of synthesized phenothiazines

Krystian Pluta et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)

Review Immunology

Efflux as a mechanism for drug resistance in Mycobacterium tuberculosis

Pedro Eduardo Almeida da Silva et al.

FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2011)

Article Biotechnology & Applied Microbiology

The role of ABC efflux pump, Rv1456c-Rv1457c-Rv1458c, from Mycobacterium tuberculosis clinical isolates in China

Pei Hao et al.

FOLIA MICROBIOLOGICA (2011)

Article Infectious Diseases

Low rate of fluoroquinolone resistance in Mycobacterium tuberculosis isolates from northern Tanzania

Jossy van den Boogaard et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)

Review Infectious Diseases

Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs

Pedro Eduardo Almeida Da Silva et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)

Article Microbiology

Rv1218c, an ABC Transporter of Mycobacterium tuberculosis with Implications in Drug Discovery

Meenakshi Balganesh et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)

Article Infectious Diseases

Time to detection of the growth of Mycobacterium tuberculosis in MGIT 960 for determining the early bactericidal activity of antituberculosis agents

A. H. Diacon et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2010)

Article Biochemistry & Molecular Biology

MIRU-VNTRplus: a web tool for polyphasic genotyping of Mycobacterium tuberculosis complex bacteria

Thomas Weniger et al.

NUCLEIC ACIDS RESEARCH (2010)

Review Microbiology

A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance

G. E. Louw et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)

Article Microbiology

Role of the Mycobacterium tuberculosis P55 Efflux Pump in Intrinsic Drug Resistance, Oxidative Stress Responses, and Growth

Santiago Ramon-Garcia et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)

Review Infectious Diseases

Fitness cost of drug resistance in Mycobacterium tuberculosis

S. Gagneux

CLINICAL MICROBIOLOGY AND INFECTION (2009)

Article Multidisciplinary Sciences

Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis

M. Analise Zaunbrecher et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Biochemical Research Methods

Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli

Laura Paixão et al.

Journal of Biological Engineering (2009)

Article Microbiology

mmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis

MR Pasca et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)

Article Multidisciplinary Sciences

Inhibitors of type IINADH:-menaquinone oxidoreductase represent a class of antitubercular drugs

EA Weinstein et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Microbiology

Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis

CE Maus et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)

Article Microbiology

Rv2686c-rv2687c-rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis

MR Pasca et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)

Article Microbiology

Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis

D Ordway et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)

Article Microbiology

Characterization of P55, a multidrug efflux pump in Mycobacterium bovis and Mycobacterium tuberculosis

PEA Silva et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)